Combined with external γ-ray radiation therapy, it can trigger a cascade of immunogenic cell death (ICD) in tumor cells and deplete tryptophan by inhibiting IDO-1, reversing the immunosuppressive tumor microenvironment [213]. Here, IDO1 is linked to neoplasm.